Indications |
Inhalation Maintenance therapy in chronic obstructive pulmonary disease Adult: >18 yr: 1 cap (18 mcg of tiotropium) inhaled daily, with the inhalation device, at the same time of day.
|
||||
Contraindications |
Hypersensitivity to atropine and its derivatives (e.g. ipratropium). | ||||
Warnings / Precautions |
Narrow-angle glaucoma; prostatic hypertrophy or bladder-neck obstruction; renal impairment. Pregnancy and lactation. Discontinue if immediate hypersensitivity (e.g. angioedema) or paradoxical bronchospasm occurs. Discontinue if eye pain, red eye, visual halos, and other signs of acute narrow-angle glaucoma. | ||||
Adverse Reactions |
Dry mouth, constipation, cough and local irritation, tachycardia, urinary retention, UTI, upper respiratory tract infection, hypersensitivity reactions, pupil dilation, blurred vision, myalgia, dyspepsia, rash. Pharyngitis, sinusitis, rhinitis and epistaxis reported with the use of inhalation powder. | ||||
Mechanism of Actions |
Tiotropium bromide, a long-acting quaternary ammonium antimuscarinic, is structurally related to ipratropium. It is a nonselective competitive antagonist of muscarinic (M1-M5) receptors and causes bronchodilation by inhibiting the actions of acetylcholine and other cholinergic stimuli at M<290>3<>190> receptors in the smooth muscle of the respiratory tract. Absorption: Bioavailability 20% (lungs). Distribution: Protein-binding: 72%. Metabolism: Undergoes some metabolism by non-enzymatic cleavage and by cytochrome P450 isoenzymes CYP2D6 and CYP3A4. Excretion: Excreted largely unchanged in urine. Terminal half-life: 5-6 days. |
||||
Storage Conditions |
Inhalation: Store at 15-30°C (59-86°F). Do not store in the inhalation device. | ||||
ATC Classification |
R03BB04 - tiotropium bromide ; Belongs to the class of other inhalants used in the treatment of obstructive airway diseases, anticholinergics. | ||||
Storage |
Inhalation: Store at 15-30°C (59-86°F). Do not store in the inhalation device. | ||||
Available As |
|
Tiotropium Bromide
Post Review about Tiotropium Bromide Click here to cancel reply.
Tiotropium Bromide Containing Brands
Tiotropium Bromide is used in following diseases
Drug - Drug Interactions of Tiotropium Bromide
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.